BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 2828799)

  • 1. Ability of corticotropin releasing hormone to stimulate cortisol secretion independent from pituitary adrenocorticotropin.
    Fehm HL; Holl R; Späth-Schwalbe E; Born J; Voigt KH
    Life Sci; 1988; 42(6):679-86. PubMed ID: 2828799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hexarelin, a synthetic growth-hormone releasing peptide, shows no interaction with corticotropin-releasing hormone and vasopressin on adrenocorticotropin and cortisol secretion in humans.
    Arvat E; Maccagno B; Ramunni J; Di Vito L; Broglio F; Deghenghi R; Camanni F; Ghigo E
    Neuroendocrinology; 1997 Dec; 66(6):432-8. PubMed ID: 9430449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adrenocorticotropin- and cortisol-releasing effect of hexarelin, a synthetic growth hormone-releasing peptide, in normal subjects and patients with Cushing's syndrome.
    Ghigo E; Arvat E; Ramunni J; Colao A; Gianotti L; Deghenghi R; Lombardi G; Camanni F
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2439-44. PubMed ID: 9253314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of hypothalamo-pituitary-adrenocortical function in children by human corticotropin-releasing hormone (MCI-028) test.
    Tanaka T; Hibi I; Shimizu N; Imura H; Tanaka K; Fukata J; Fujieda K; Ichimura T; Kuribayashi T; Ito K
    Endocr J; 1993 Oct; 40(5):581-9. PubMed ID: 7951524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human corticotropin-releasing hormone test in patients with hypothalamo-pituitary-adrenocortical disorders.
    Fukata J; Shimizu N; Imura H; Hibi I; Tanaka K; Tanaka T; Nakagawa S; Takebe K; Kimura K; Yoshinaga K
    Endocr J; 1993 Oct; 40(5):597-606. PubMed ID: 7951526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction between glucagon and human corticotropin-releasing hormone or vasopressin on ACTH and cortisol secretion in humans.
    Arvat E; Maccagno B; Ramunni J; Maccario M; Giordano R; Broglio F; Camanni F; Ghigo E
    Eur J Endocrinol; 2000 Jul; 143(1):99-104. PubMed ID: 10870037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atrial natriuretic factor inhibits the CRH-stimulated secretion of ACTH and cortisol in man.
    Kellner M; Wiedemann K; Holsboer F
    Life Sci; 1992; 50(24):1835-42. PubMed ID: 1317939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of pulsatile human corticotropin-releasing hormone administration on the adrenal insufficiency that follows cure of Cushing's disease.
    Avgerinos PC; Nieman LK; Oldfield EH; Loughlin T; Barnes KM; Loriaux DL; Cutler GB
    J Clin Endocrinol Metab; 1989 May; 68(5):912-6. PubMed ID: 2541160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of stimulated and spontaneous adrenocorticotropin secretory dynamics identifies distinct components of cortisol feedback inhibition in healthy humans.
    Dorin RI; Ferries LM; Roberts B; Qualls CR; Veldhuis JD; Lisansky EJ
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3883-91. PubMed ID: 8923833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of repetitive administration of corticotropin-releasing hormone combined with lysine vasopressin on plasma adrenocorticotropin and cortisol levels in secondary adrenocortical insufficiency.
    Fukata J; Usui T; Tsukada T; Nakai Y; Koh T; Ishihara T; Tanaka I; Uchida K; Yoshimasa T; Nakano R
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1624-31. PubMed ID: 2172283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulation by peptide histidine methionine (PHM) of adrenocorticotropin secretion in patients with Cushing's disease: a comparison with the effect of vasoactive intestinal peptide (VIP) and a study on the effect of combined administration of corticotropin-releasing hormone with PHM or VIP.
    Watanobe H; Tamura T
    J Clin Endocrinol Metab; 1994 Jun; 78(6):1372-7. PubMed ID: 8200939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corticotropin-independent effect of ovine corticotropin-releasing hormone on cortisol release in man.
    Azar ST; Turner A; Melby JC
    Am J Med Sci; 1992 Apr; 303(4):217-21. PubMed ID: 1314020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cushing's syndrome with a large pituitary adenoma producing both corticotropin-releasing hormone (CRH) and adrenocorticotropin (ACTH).
    Yamada Y; Ohashi A; Inoue T; Sakaguchi K; Tsujimura T; Okamoto D; Itatani H; Fujimoto N; Kusaka K; Fushimi H
    Intern Med; 2002 Jul; 41(7):549-54. PubMed ID: 12132523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The regulation of adrenocorticotrophic hormone receptor by corticotropin-releasing hormone in human fetal adrenal definitive/transitional zone cells.
    Rehman KS; Sirianni R; Parker CR; Rainey WE; Carr BR
    Reprod Sci; 2007 Sep; 14(6):578-87. PubMed ID: 17959886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The corticotropin-releasing hormone test in normal short children: comparison of plasma adrenocorticotropin and cortisol responses to human corticotropin-releasing hormone and insulin-induced hypoglycemia.
    Goji K
    Acta Endocrinol (Copenh); 1989 Mar; 120(3):390-4. PubMed ID: 2538990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The antiglucocorticoid and antiprogestin steroid RU 486 suppresses the adrenocorticotropin response to ovine corticotropin releasing hormone in man.
    Laue L; Chrousos GP; Loriaux DL; Barnes K; Munson P; Nieman L; Schaison G
    J Clin Endocrinol Metab; 1988 Feb; 66(2):290-3. PubMed ID: 2828406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose-response effects of exogenous pulsatile human corticotropin-releasing hormone on adrenocorticotropin, cortisol, and gonadotropin concentrations in agonadal women.
    Thomas MA; Rebar RW; LaBarbera AR; Pennington EJ; Liu JH
    J Clin Endocrinol Metab; 1991 Jun; 72(6):1249-54. PubMed ID: 1851183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human corticotropin-releasing hormone test in normal subjects and patients with hypothalamic, pituitary or adrenocortical disorders.
    Fukata J; Nakai Y; Imura H; Abe K; Aono T; Demura H; Fujita T; Hibi I; Ibayashi H; Igarashi M
    Endocrinol Jpn; 1988 Jun; 35(3):491-502. PubMed ID: 2848692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adrenocorticotropin and cortisol responses to ovine corticotropin-releasing factor in alcohol dependence disorder. Preliminary report.
    Bailly D; Dewailly D; Beuscart R; Couplet G; Dumont P; Racadot A; Fossati P; Parquet PJ
    Horm Res; 1989; 31(1-2):72-5. PubMed ID: 2542148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of a long-acting somatostatin analogue on pituitary-adrenocortical secretion in normal human subjects.
    Itoh S; Tanaka K; Kumage M; Shimizu N
    Endocrinol Jpn; 1990 Feb; 37(1):131-9. PubMed ID: 2166654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.